Loading…
Reported covered position: Legislative Assistant; Rep. Mike Bilirakis
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes.
Client: SMALL REFINERS OF AMERICA · Firm: SIDLEY AUSTIN LLP
H.R. 1346, Nationwide Consumer and Fuel Retailer Choice Act of 2025
To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes.
Client: SMALL REFINERS OF AMERICA · Firm: SIDLEY AUSTIN LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AVEM HEALTH PARTNERS via SIDLEY AUSTIN LLP
2026 · third_quarter · Q3
Improving access to quality healthcare in rural communities
Improving access to quality healthcare in rural communities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| INTREXON CORPORATION |
| 25 |
| 2016–2021 |
| SUNRISE MEDICAL (US) LLC | 23 | 2021–2026 |
| CULLIGAN INTERNATIONAL COMPANY | 22 | 2018–2023 |
| AQUABOUNTY TECHNOLOGIES, INC. | 20 | 2019–2023 |
| PUROLITE CORPORATION | 18 | 2018–2022 |
| YUM CHINA HOLDINGS, INC. | 16 | 2020–2023 |
| ENVOY MEDICAL CORPORATION | 15 | 2023–2026 |
| PERMOBIL, INC. | 15 | 2015–2019 |
| ENCHANT ENERGY CORPORATION | 14 | 2020–2023 |
| EQUILIBRIUM CAPITAL | 14 | 2020–2023 |
| CALYXT, INC. | 13 | 2018–2021 |
| DIGICERT, INC. | 13 | 2020–2023 |
| ILLUMINA, INC. | 13 | 2021–2023 |
| ENESCO, LLC | 12 | 2020–2022 |
| KALDEROS, INC. | 10 | 2020–2022 |
| SHIRE PHARMACEUTICALS LLC | 10 | 2016–2018 |
| GARMIN INTERNATIONAL, INC. | 9 | 2016–2018 |
| COMDATA, INC. | 8 | 2021–2022 |
| TAYLOR FRESH FOODS, INC | 8 | 2025–2026 |
| GW PHARMA INC. | 7 | 2015–2016 |
| NOVOCURE INC. | 7 | 2013–2015 |
| WILLIS LEASE FINANCE CORPORATION | 7 | 2020–2021 |
| CATALYST PAPER | 6 | 2015–2016 |
| LIFE TECHNOLOGIES CORPORATION | 6 | 2012 |
| PTC THERAPEUTICS, INC. | 6 | 2016–2017 |
| KARYOPHARM THERAPEUTICS | 5 | 2025–2026 |
| LIFESCIENCE LOGISTICS, LLC | 5 | 2024–2025 |
| ONYX PHARMACEUTICALS, INC. | 5 | 2013–2014 |
| THE MEDICINES COMPANY | 5 | 2015–2016 |
| DUKE UNIVERSITY MEDICAL CENTER | 4 | 2026 |
| HEMOPHILIA FEDERATION OF AMERICA | 4 | 2026 |
| THERMO FISHER SCIENTIFIC | 4 | 2016 |
| EUROIMMUN US, INC. | 3 | 2016 |
| Exact Sciences Corporation | 3 | 2015–2016 |
| GRIFOLS INC | 3 | 2012–2013 |
| HINDALCO INDUSTRIES LTD. | 3 | 2023 |
| INTERCEPT PHARMACEUTICALS, INC. | 3 | 2024 |
| LEADIANT BIOSCIENCES, INC. | 3 | 2018–2019 |
| MELINTA THERAPEUTICS | 3 | 2018 |
| OCI HOLDINGS COMPANY LTD. | 3 | 2024–2025 |
| SMALL REFINERS OF AMERICA | 3 | 2026 |
| VERTOS MEDICAL | 3 | 2016 |
| ANNEXON BIOSCIENCES | 2 | 2025 |
| ASSOCIATION OF CLINICIANS FOR THE UNDERSERVED | 2 | 2015 |
| AVEM HEALTH PARTNERS | 2 | 2026 |
| IHEART MEDIA | 2 | 2024 |
| THE MEGAWATT GROUP | 2 | 2026 |
H.R. 1346, Nationwide Consumer and Fuel Retailer Choice Act of 2025
To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes.
Client: SMALL REFINERS OF AMERICA · Firm: SIDLEY AUSTIN LLP
H.R. 1346, Nationwide Consumer and Fuel Retailer Choice Act of 2025
Hearing Device Coverage Clarification Act
Client: ENVOY MEDICAL CORPORATION · Firm: SIDLEY AUSTIN LLP
Support for H.R. 1921/S. 983, the Hearing Device Coverage Clarification Act
Hearing Device Coverage Clarification Act
Client: ENVOY MEDICAL CORPORATION · Firm: SIDLEY AUSTIN LLP
Support for H.R. 1921/S. 983, the Hearing Device Coverage Clarification Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Client: DUKE UNIVERSITY MEDICAL CENTER · Firm: SIDLEY AUSTIN LLP
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Hearing Device Coverage Clarification Act
Client: ENVOY MEDICAL CORPORATION · Firm: SIDLEY AUSTIN LLP
Support for H.R. 1921/S. 983, the Hearing Device Coverage Clarification Act
Hearing Device Coverage Clarification Act
Client: ENVOY MEDICAL CORPORATION · Firm: SIDLEY AUSTIN LLP
Support for H.R. 1921/S. 983, the Hearing Device Coverage Clarification Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Allow States and Victims to Fight Online Sex Trafficking Act of 2017
Client: CRAIGSLIST, INC. · Firm: SIDLEY AUSTIN LLP
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
H.R. 748-116th Congress (2019-2020), agriculture infrastructure
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Holding Foreign Companies Accountable Act
Client: YUM CHINA HOLDINGS, INC. · Firm: SIDLEY AUSTIN LLP
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
2026 · third_quarter · RR
improving access to quality healthcare in rural communities
improving access to quality healthcare in rural communities
THE MEGAWATT GROUP via SIDLEY AUSTIN LLP
2026 · third_quarter · Q3
Resolution of a customs matter
Filing targets: HOUSE OF REPRESENTATIVES
SMALL REFINERS OF AMERICA via SIDLEY AUSTIN LLP
2026 · third_quarter · Q3
H.R. 1346, Nationwide Consumer and Fuel Retailer Choice Act of 2025
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
DUKE UNIVERSITY MEDICAL CENTER via SIDLEY AUSTIN LLP
2026 · third_quarter · Q3
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES
HEMOPHILIA FEDERATION OF AMERICA via SIDLEY AUSTIN LLP
2026 · third_quarter · Q3
Health policy issues related to bleeding disorders.
Filing targets: HOUSE OF REPRESENTATIVES
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2026 · third_quarter · Q3
Support for H.R. 1921/S. 983, the Hearing Device Coverage Clarification Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2026 · second_quarter · 2T
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MEGAWATT GROUP via SIDLEY AUSTIN LLP
2026 · third_quarter · RR
Resolution of a customs matter
HEMOPHILIA FEDERATION OF AMERICA via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
Health policy issues related to bleeding disorders.
Filing targets: HOUSE OF REPRESENTATIVES
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
Support for H.R. 1921/S. 983, the Hearing Device Coverage Clarification Act
Filing targets: HOUSE OF REPRESENTATIVES
DUKE UNIVERSITY MEDICAL CENTER via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation.
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL REFINERS OF AMERICA via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
H.R. 1346, Nationwide Consumer and Fuel Retailer Choice Act of 2025
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2026 · second_quarter · Q2
Rare disease policy, drug approval process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL REFINERS OF AMERICA via SIDLEY AUSTIN LLP
2026 · second_quarter · RR
H.R. 1346, Nationwide Consumer and Fuel Retailer Choice Act of 2025
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2026 · first_quarter · Q1
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation.
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2026 · first_quarter · Q1
Rare disease policy, drug approval process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2026 · first_quarter · Q1
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY MEDICAL CENTER via SIDLEY AUSTIN LLP
2026 · first_quarter · Q1
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMOPHILIA FEDERATION OF AMERICA via SIDLEY AUSTIN LLP
2026 · first_quarter · Q1
Health policy issues related to bleeding disorders.
Filing targets: HOUSE OF REPRESENTATIVES
DUKE UNIVERSITY MEDICAL CENTER via SIDLEY AUSTIN LLP
2026 · first_quarter · RR
Federal funding for NCBI, H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
Federal funding for NCBI, H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
HEMOPHILIA FEDERATION OF AMERICA via SIDLEY AUSTIN LLP
2026 · first_quarter · RR
Health policy issues related to bleeding disorders
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2025 · fourth_quarter · 4T
Legislative and federal agency activities related to the Stem Cell Act, pediatric research, and appropriations issues
Legislative and federal agency activities related to the Stem Cell Act, pediatric research, and appropriations issues
Legislative and federal agency activities related to the Stem Cell Act, pediatric research, and appropriations issues
Filing targets: HOUSE OF REPRESENTATIVES
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2025 · fourth_quarter · Q4
Food regulation
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2025 · fourth_quarter · Q4
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation.
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2025 · fourth_quarter · Q4
Rare disease policy, drug approval process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2025 · fourth_quarter · Q4
Medicare reimbursement related to fully implanted middle ear hearing devices.
Filing targets: HOUSE OF REPRESENTATIVES
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2025 · fourth_quarter · Q4
Legislative and federal agency activities related to the Stem Cell Act, pediatric research, and appropriations issues
Legislative and federal agency activities related to the Stem Cell Act, pediatric research, and appropriations issues
Legislative and federal agency activities related to the Stem Cell Act, pediatric research, and appropriations issues
Filing targets: HOUSE OF REPRESENTATIVES
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2025 · fourth_quarter · RA
Rare disease policy, drug approval process
KARYOPHARM THERAPEUTICS via SIDLEY AUSTIN LLP
2025 · fourth_quarter · RR
Rare disease policy, drug approval process
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2025 · third_quarter · 3T
Advise regarding development of legislative strategy related to pharmaceutical products
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2025 · third_quarter · Q3
Food regulation
Food regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2025 · third_quarter · Q3
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation.
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFESCIENCE LOGISTICS, LLC via SIDLEY AUSTIN LLP
2025 · third_quarter · 3T
Healthcare warehousing
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2025 · third_quarter · Q3
Medicare reimbursement related to fully implanted middle ear hearing devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2025 · third_quarter · Q3
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2025 · second_quarter · Q2
Advise regarding development of legislative strategy related to pharmaceutical products
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2025 · second_quarter · Q2
Food regulation
Food regulation
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2025 · second_quarter · Q2
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation.
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFESCIENCE LOGISTICS, LLC via SIDLEY AUSTIN LLP
2025 · second_quarter · Q2
Healthcare warehousing
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2025 · second_quarter · Q2
Medicare reimbursement related to fully implanted middle ear hearing devices.
Filing targets: HOUSE OF REPRESENTATIVES
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2025 · second_quarter · Q2
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANNEXON BIOSCIENCES via SIDLEY AUSTIN LLP
2025 · second_quarter · Q2
Rare disease policy, drug approval process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANNEXON BIOSCIENCES via SIDLEY AUSTIN LLP
2025 · second_quarter · RR
Rare disease policy, drug approval process
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2025 · first_quarter · Q1
Food regulation
Food regulation
Food regulation
Food regulation
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2025 · first_quarter · Q1
Advise regarding development of legislative strategy related to pharmaceutical products
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2025 · first_quarter · Q1
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation.
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitation technology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: SENATE
OCI HOLDINGS COMPANY LTD. via SIDLEY AUSTIN LLP
2025 · first_quarter · Q1
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2025 · first_quarter · Q1
Medicare reimbursement related to fully implanted middle ear hearing devices.
Filing targets: HOUSE OF REPRESENTATIVES
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2025 · first_quarter · Q1
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Legislative and Federal agency activities related to the Stem Cell Act, transport of blood stem cells and pediatric research and appropriations issues.
Filing targets: HOUSE OF REPRESENTATIVES
TAYLOR FRESH FOODS, INC via SIDLEY AUSTIN LLP
2025 · first_quarter · RR
Regulation of food safety
Regulation of food safety
Regulation of food safety
Regulation of food safety
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2024 · fourth_quarter · Q4
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES
OCI HOLDINGS COMPANY LTD. via SIDLEY AUSTIN LLP
2024 · fourth_quarter · Q4
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFESCIENCE LOGISTICS, LLC via SIDLEY AUSTIN LLP
2024 · fourth_quarter · Q4
Healthcare warehousing
INTERCEPT PHARMACEUTICALS, INC. via SIDLEY AUSTIN LLP
2024 · fourth_quarter · Q4
FDA's regulation of rare disease drugs
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2024 · fourth_quarter · Q4
Reimbursement for fully implanted middle ear device
Filing targets: HOUSE OF REPRESENTATIVES
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2024 · fourth_quarter · Q4
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2024 · third_quarter · Q3
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES
LIFESCIENCE LOGISTICS, LLC via SIDLEY AUSTIN LLP
2024 · third_quarter · Q3
Healthcare warehousing
INTERCEPT PHARMACEUTICALS, INC. via SIDLEY AUSTIN LLP
2024 · third_quarter · Q3
FDA's regulation of rare disease drugs
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2024 · third_quarter · Q3
Reimbursement for fully implanted middle ear device
Filing targets: HOUSE OF REPRESENTATIVES
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2024 · third_quarter · Q3
The Legislative and Federal agency activities: related to the reauthorization of the Federal Aviation Act and the transport of blood stem cells.
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
OCI HOLDINGS COMPANY LTD. via SIDLEY AUSTIN LLP
2024 · fourth_quarter · RR
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
We are lobbying on issues related to the importation and development of solar energy solutions to the United States.
INTERCEPT PHARMACEUTICALS, INC. via SIDLEY AUSTIN LLP
2024 · third_quarter · RR
FDAs regulation of rare disease drugs
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2024 · second_quarter · Q2
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES
LIFESCIENCE LOGISTICS, LLC via SIDLEY AUSTIN LLP
2024 · second_quarter · Q2
Healthcare warehousing
IHEART MEDIA via SIDLEY AUSTIN LLP
2024 · second_quarter · Q2
Antitrust issues related to media contracts
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2024 · second_quarter · Q2
Reimbursement for fully implanted middle ear device
Filing targets: HOUSE OF REPRESENTATIVES
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2024 · second_quarter · Q2
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
The Legislative and Federal agency activities: related to the reauthorization of the Federal Aviation Act and the transport of blood stem cells.
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2024 · first_quarter · Q1
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2024 · first_quarter · Q1
Reimbursement for fully implanted middle ear device
Filing targets: HOUSE OF REPRESENTATIVES
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2024 · first_quarter · Q1
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
The Legislative and Federal agency activities: related to the reauthorization of the Federal Aviation Act and the transport of blood stem cells.
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
IHEART MEDIA via SIDLEY AUSTIN LLP
2024 · second_quarter · RR
Antitrust issues related to media contracts
YUM CHINA HOLDINGS, INC. via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
Regulatory and legislative activities related to pharmaceutical products
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
MEDELA LLC via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
Issues related to infant nutrition and health, maternal and child health, and breastfeeding support.
Filing targets: SENATE
ILLUMINA, INC. via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
We will lobby to support Illumina's efforts to reacquire GRAIL, Inc.
We will lobby to support Illumina's efforts to reacquire GRAIL, Inc.
HINDALCO INDUSTRIES LTD. via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
Hindalco Industries Limited (Hindalco) is a respondent in the antidumping (AD) and countervailing (CV) duty proceedings concerning Common Alloy Aluminum Sheet (CAAS) from India being conducted by the U.S. Department of Commerce (Commerce), Case Nos. A-533-895 & C-533-896.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
Reimbursement for fully implanted middle ear device
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
Legislative and Federal agency activities related to the Stem Cell Act of 2021 and the transport of blood stem cells.
The Legislative and Federal agency activities: related to the reauthorization of the Federal Aviation Act and the transport of blood stem cells.
AQUABOUNTY TECHNOLOGIES, INC. via SIDLEY AUSTIN LLP
2023 · fourth_quarter · Q4
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Legislative and Federal agency activities: related to the Farm Bill.
CORD BLOOD ASSOCIATION via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
The Legislative and Federal agency activities: related to the reauthorization of the Federal Aviation Act.
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
AQUABOUNTY TECHNOLOGIES, INC. via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Legislative and Federal agency activities: related to the Farm Bill.
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
YUM CHINA HOLDINGS, INC. via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Filing targets: HOUSE OF REPRESENTATIVES
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
Regulation and legislative activities related to pharmaceutical products
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
Issues related to infant nutrition and health, maternal and child health, and breastfeeding support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
We will lobby to support Illumina's efforts to reacquire GRAIL, Inc.
We will lobby to support Illumina's efforts to reacquire GRAIL, Inc.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HINDALCO INDUSTRIES LTD. via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
Hindalco Industries Limited (Hindalco) is a respondent in the antidumping (AD) and countervailing (CV) duty proceedings concerning Common Alloy Aluminum Sheet (CAAS) from India being conducted by the U.S. Department of Commerce (Commerce), Case Nos. A-533-895 & C-533-896.
ENVOY MEDICAL CORPORATION via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
Reimbursement for fully implanted middle ear device
Reimbursement for fully implanted middle ear device
Reimbursement for fully implanted middle ear device
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CULLIGAN INTERNATIONAL COMPANY via SIDLEY AUSTIN LLP
2023 · third_quarter · 3T
Proposed tarrifs on water filtration and treatment products and parts from China.
Proposed tarrifs on water filtration and treatment products and parts from China.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
CRAIGSLIST, INC. via SIDLEY AUSTIN LLP
2023 · third_quarter · Q3
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
HINDALCO INDUSTRIES LTD. via SIDLEY AUSTIN LLP
2023 · third_quarter · RR
Hindalco Industries Limited (Hindalco) is a respondent in the antidumping (AD) and countervailing (CV) duty proceedings concerning Common Alloy Aluminum Sheet (CAAS) from India being conducted by the U.S. Department of Commerce (Commerce), Case Nos. A-533-895 & C-533-896.
YUM CHINA HOLDINGS, INC. via SIDLEY AUSTIN LLP
2023 · second_quarter · Q2
S. 945/H.R. 7000 Holding Foreign Companies Accountable Act
Filing targets: HOUSE OF REPRESENTATIVES
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2023 · second_quarter · Q2
Regulation and legislative activities related to pharmaceutical products
SUNRISE MEDICAL (US) LLC via SIDLEY AUSTIN LLP
2023 · second_quarter · Q2
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
General issues related to Medicare and Medicaid reimbursement, congressional and regulatory initiatives related to complex rehabilitationtechnology, establishing permanent remote telehealth options for complex rehabilitation technology, right to repair legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDELA LLC via SIDLEY AUSTIN LLP
2023 · second_quarter · Q2
Issues related to infant nutrition and health, maternal and child health, and breastfeeding support.
Issues related to product counterfeiting and IP protection.
Filing targets: SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
The Legislative and Federal agency activities: related to the reauthorization of the Federal Aviation Act and the transport of blood stem cells.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative and Federal agency activities related to the Stem Cell Act of 2021, transport of blood stem cells and pediatric research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative and Federal agency activities related to the Stem Cell Act of 2021 and transport of blood stem cells
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative and Federal agency activities related to the appropriations process.
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, White House Office
Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods.
Legislative and Federal agency activities related to the Stem Cell Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
S. 1693, Stop Enabling Sex Traffickers Act of 2017 and H.R. 1865, Allow States and Victims to Fight Online Sex Trafficking Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE